Bugaj, L. J., Sabnis, A. J., Mitchell, A., Garbarino, J. E., Toettcher, J. E., Bivona, T. G., & Lim, W. A. (2018). Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway. Science.

Bugaj, L. J., A. J. Sabnis, A. Mitchell, J. E. Garbarino, J. E. Toettcher, T. G. Bivona, und W. A. Lim. "Cancer Mutations and Targeted Drugs Can Disrupt Dynamic Signal Encoding By the Ras-Erk Pathway." Science 2018.

Bugaj, L. J., et al. "Cancer Mutations and Targeted Drugs Can Disrupt Dynamic Signal Encoding By the Ras-Erk Pathway." Science 2018.